Procyrion: Funding, Investors & Team (Sep 2026)
Procyrion develops technology solutions and offers a catheter-based circulatory support technologies. One in five adults over the age of 40 will develop heart failure in his or her lifetime. For the sickest patients, only 1% receive treatment annually due to scarcity, cost, and high risk of current solutions. Procyrion, has developed a solution: Aortix is a circulatory support pump implanted without surgery. Thinner than a #2 pencil, a cardiologist can implant Aortix through a catheter in the leg, deploying it between the heart and the kidneys to unload the failing heart and perfuse vital organs. This first-in-class device allows the heart to rest and heal while correcting the fluid imbalance. The company was founded in 2005 and is based in Houston, Texas.
Procyrion has raised $47.7M across 1 funding round on record, the most recent a Series E of $47.7M announced in Feb 2024.
That round is above the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.
Procyrion Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Procyrion Funding Rounds
Procyrion Founders and Leadership Team
No contact details are on record for this team yet.
Procyrion Funding Compared to Other Health Care Startups
Procyrion's latest round of $47.7M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Procyrion in Health Care and Houston
Companies Similar to Procyrion
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Procyrion Funding FAQs
What does Procyrion do?
Procyrion develops technology solutions and offers a catheter-based circulatory support technologies. One in five adults over the age of 40 will develop heart failure in his or her lifetime. For the sickest patients, only 1% receive treatment annually due to scarcity, cost, and high risk of current solutions. Procyrion, has developed a solution: Aortix is a circulatory support pump implanted without surgery. Thinner than a #2 pencil, a cardiologist can implant Aortix through a catheter in the leg, deploying it between the heart and the kidneys to unload the failing heart and perfuse vital organs. This first-in-class device allows the heart to rest and heal while correcting the fluid imbalance. The company was founded in 2005 and is based in Houston, Texas.
How much funding has Procyrion raised?
Procyrion has raised $47.7M across 1 round on record. The most recent is a Series E of $47.7M announced in Feb 2024.
When did Procyrion last raise funding?
Procyrion's most recent funding round on record is a Series E of $47.7M, announced in Feb 2024.
Who founded Procyrion?
FundedIQ lists Reynolds M Delgado Iii (Founder) at Procyrion.
Where is Procyrion headquartered?
Procyrion is based in Houston, Texas, United States.
How many employees does Procyrion have?
Procyrion is in the 11-50 employee band.
How does Procyrion's funding compare to other Health Care startups?
Procyrion's latest round of $47.7M is above the $5.0M median round size for Health Care companies on FundedIQ across 3,654 tracked companies over the last two years.
About FundedIQ's Procyrion Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Procyrion is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.